Get started
Author

Kevin De Muynck

Observed names: De Muynck, Kevin, Kevin de Muynck
ORCID: 0000-0003-3974-8473
Observed ORCID: 0000-0003-3974-8473
OpenAlex ID: A5043102776
Differential effects of selective- and pan-PPAR agonists on experimental steatohepatitis and hepatic macrophages☆
2020 · Sander Lefere, Tobias Puengel, et al. · Journal of Hepatology · 307
Rodent models of cholestatic liver disease: A practical guide for translational research
2021 · Eva Gijbels, Alanah Pieters, et al. · Liver International · 75
PDF
Osteopontin characterizes bile duct–associated macrophages and correlates with liver fibrosis severity in primary sclerosing cholangitis
2023 · Kevin De Muynck, Lander Heyerick, et al. · Hepatology · 62
The Gut–Liver Axis in Chronic Liver Disease: A Macrophage Perspective
2021 · Kevin De Muynck, Bart Vanderborght, et al. · Cells · 45
PDF
Mapping cytoskeletal protein function in cells by means of nanobodies
2013 · Isabel Van Audenhove, Katrien Van Impe, et al. · Cytoskeleton · 40
Kupffer Cells Contested as Early Drivers in the Pathogenesis of Primary Sclerosing Cholangitis
2023 · Kevin De Muynck, Bart Vanderborght, et al. · American Journal Of Pathology · 18
PDF
Effect of isoform-specific HIF-1α and HIF-2α antisense oligonucleotides on tumorigenesis, inflammation and fibrosis in a hepatocellular carcinoma mouse model
2020 · Bart Vanderborght, Kevin De Muynck, et al. · Oncotarget · 17
PDF
Transient Kupffer cell depletion and subsequent replacement by infiltrating monocyte‐derived cells does not alter the induction or progression of hepatocellular carcinoma
2023 · Bart Vanderborght, Kevin De Muynck, et al. · International Journal of Cancer · 9
PDF
Targeting osteopontin to treat primary sclerosing cholangitis
2024 · Kevin De Muynck, Lindsey Devisscher · Current Opinion in Gastroenterology · 2
Systematic comparison of experimental and human obstructive cholestasis reveals conservation of canonical pathway activation and biomarkers relevant for cholestatic liver disease
2022 · Eva Gijbels, Kevin De Muynck, et al. · Genes & Diseases · 2
PDF
SAT-151-YI The role of interleukin-8 in primary sclerosing cholangitisassociated immune cell dysregulation
2024 · Lander Heyerick, Kevin De Muynck, et al. · Journal of Hepatology · 1
Interleukin-8–driven monocyte activation in primary sclerosing cholangitis: Insights from single-cell analysis and humanized immune system mice
2026 · Lander Heyerick, Zenzi De Vos, et al. · JHEP Reports
Early Kupffer cell depletion does not affect hepatocellular carcinoma progression in mice
2022 · Bart Van Derborght, Kevin De Muynck, et al. · Journal of Hepatology
Works count: 14
Citation count: 578
H-index: 8
I10-index: 7
Year
Topic
Type